- Tytuł:
-
Efficacy and safety of long-acting recombinant fusion protein linking
factor IX with albumin in haemophilia B patients undergoing surgery. - Autorzy:
- Źródło:
- Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2016 Jul; Vol. 22 (4), pp. e259-66. Date of Electronic Publication: 2016 Jun 22.
- Typ publikacji:
- Clinical Trial, Phase III; Journal Article; Multicenter Study
- MeSH Terms:
-
Coagulants/*therapeutic use
Factor IX /*therapeutic use
Hemophilia B/*drug therapy
Serum Albumin/*genetics
Adolescent ; Adult ; Child ;Factor IX /genetics ;Factor IX /metabolism ; Half-Life ; Hemophilia B/pathology ; Hemorrhage/prevention & control ; Humans ; Middle Aged ; Postoperative Period ; Preoperative Care ; Recombinant Fusion Proteins/biosynthesis ; Recombinant Fusion Proteins/pharmacokinetics ; Recombinant Fusion Proteins/therapeutic use ; Serum Albumin/metabolism ; Severity of Illness Index ; Surgical Procedures, Operative ; Young Adult
Czasopismo naukowe